Bayer Intellectual Property GmbH v. InvaGen Pharmaceuticals, Inc.
1:16-cv-00064
Overview
Parties
Defendant
Plaintiff
Janssen Pharmaceuticals, Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Bayer Pharma AG NPE (Individual / Inventor)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Bayer Intellectual Property GmbH Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
Mylan Pharmaceuticals Inc. et al. v. Bayer Intellectual Property GmbH et al.
Mylan Pharmaceuticals Inc. et al. v. Bayer Intellectual Property GmbH et al.
Mylan Pharmaceuticals Inc et al. v. Bayer Intellectual Property GmbH et al.
Bayer Intellectual Property GMBH v. Breckenridge Pharmaceutical Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7157456
Substituted oxazolidinones and their use in the field of blood coagulation
|
Filed: 2000-12-11
Issued: 2007-01-02
|
Expired (Term Ended)
+1415d PTA
Expires: 2024-10-26
|
|
|
US7585860
Substituted oxazolidinones and their use in the field of blood coagulation
|
Filed: 2008-02-07
Issued: 2009-09-08
|
Active (1.2 yrs remaining)
Expires: 2028-02-07
|
|
|
US7592339
Substituted oxazolidinones and their use in the field of blood coagulation
|
Filed: 2006-07-27
Issued: 2009-09-22
|
Expired (Term Ended)
Expires: 2026-07-27
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
High PTA (+1415 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
0
Granted
0
Denied
0
Pending / Review
0
Motions by Category
Key Dispositive Motions & Rulings